Marvin L. White - 11 Nov 2024 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
Director
Signature
/s/ Richard S. Lindahl, Attorney-in-fact
Issuer symbol
EBS
Transactions as of
11 Nov 2024
Net transactions value
-$171,015
Form type
4
Filing time
13 Nov 2024, 16:04:50 UTC
Previous filing
19 Jul 2024
Next filing
04 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Sale $171,015 -14,287 -21% $11.97 54,092 11 Nov 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On November 11, 2024, Mr. White sold an aggregate of 14,287 shares of Emergent BioSolutions Inc. common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $11.84 - $12.11. The Company maintains a record of the transactions and copies will be provided upon request.